Literature DB >> 29610476

Mapping the in vivo fitness landscape of lung adenocarcinoma tumor suppression in mice.

Zoë N Rogers1, Christopher D McFarland2, Ian P Winters1, Jose A Seoane1,3,4, Jennifer J Brady1, Stephanie Yoon5, Christina Curtis1,3,4,6, Dmitri A Petrov7, Monte M Winslow8,9,10,11.   

Abstract

The functional impact of most genomic alterations found in cancer, alone or in combination, remains largely unknown. Here we integrate tumor barcoding, CRISPR/Cas9-mediated genome editing and ultra-deep barcode sequencing to interrogate pairwise combinations of tumor suppressor alterations in autochthonous mouse models of human lung adenocarcinoma. We map the tumor suppressive effects of 31 common lung adenocarcinoma genotypes and identify a landscape of context dependence and differential effect strengths.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29610476      PMCID: PMC6061949          DOI: 10.1038/s41588-018-0083-2

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  1 in total

1.  Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines.

Authors:  N Keshelava; J J Zuo; P Chen; S N Waidyaratne; M C Luna; C J Gomer; T J Triche; C P Reynolds
Journal:  Cancer Res       Date:  2001-08-15       Impact factor: 12.701

  1 in total
  33 in total

1.  Fitness variation across subtle environmental perturbations reveals local modularity and global pleiotropy of adaptation.

Authors:  Grant Kinsler; Kerry Geiler-Samerotte; Dmitri A Petrov
Journal:  Elife       Date:  2020-12-02       Impact factor: 8.140

Review 2.  Characterizing the ecological and evolutionary dynamics of cancer.

Authors:  Nastaran Zahir; Ruping Sun; Daniel Gallahan; Robert A Gatenby; Christina Curtis
Journal:  Nat Genet       Date:  2020-07-27       Impact factor: 38.330

Review 3.  In vivo functional screening for systems-level integrative cancer genomics.

Authors:  Julia Weber; Christian J Braun; Dieter Saur; Roland Rad
Journal:  Nat Rev Cancer       Date:  2020-07-07       Impact factor: 60.716

4.  An LKB1-SIK Axis Suppresses Lung Tumor Growth and Controls Differentiation.

Authors:  Christopher W Murray; Jennifer J Brady; Min K Tsai; Chuan Li; Ian P Winters; Rui Tang; Laura Andrejka; Rosanna K Ma; Christian A Kunder; Pauline Chu; Monte M Winslow
Journal:  Cancer Discov       Date:  2019-07-26       Impact factor: 39.397

Review 5.  "Keaping" a lid on lung cancer: the Keap1-Nrf2 pathway.

Authors:  Sarah A Best; Kate D Sutherland
Journal:  Cell Cycle       Date:  2018-08-01       Impact factor: 4.534

Review 6.  Autochthonous murine models for the study of smoker and never-smoker associated lung cancers.

Authors:  Esra A Akbay; James Kim
Journal:  Transl Lung Cancer Res       Date:  2018-08

Review 7.  Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy.

Authors:  Ferdinandos Skoulidis; John V Heymach
Journal:  Nat Rev Cancer       Date:  2019-08-12       Impact factor: 60.716

8.  Diversity in biology: definitions, quantification and models.

Authors:  Song Xu; Lucas Böttcher; Tom Chou
Journal:  Phys Biol       Date:  2020-03-19       Impact factor: 2.583

Review 9.  The causes of evolvability and their evolution.

Authors:  Joshua L Payne; Andreas Wagner
Journal:  Nat Rev Genet       Date:  2019-01       Impact factor: 53.242

10.  Quantitative In Vivo Analyses Reveal a Complex Pharmacogenomic Landscape in Lung Adenocarcinoma.

Authors:  Chuan Li; Wen-Yang Lin; Monte M Winslow; Hira Rizvi; Hongchen Cai; Christopher D McFarland; Zoe N Rogers; Maryam Yousefi; Ian P Winters; Charles M Rudin; Dmitri A Petrov
Journal:  Cancer Res       Date:  2021-07-02       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.